Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Papillary renal cell carcinoma: current progress and future directions.

Clinical genitourinary cancer - 1 Apr 2014

Twardowski Przemyslaw W, Mack Philip C, Lara Primo N

Abstract excerpt

Papillary renal cell carcinoma (pRCC) represents the second most common histologic variant of kidney cancer. It exhibits a different molecular signature than clear-cell carcinoma and is typically not associated with mutations in the VHL (von Hippel-Lindau) tumor suppressor gene. pRCC is less responsive to modern drugs introduced in the management of kidney cancer in the past decade. In this article, the heredity...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Carcinoma, Renal Cell
Share to Clinical Trials as Topic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to ErbB Receptors

Share to Kidney Neoplasms

Share to Molecular Targeted Therapy

Share to Proto-Oncogene Proteins c-met

Share to Signal Transduction

Source

Identifiers

PMID: 24629521
DOI: 10.1016/j.clgc.2013.11.013

Genes

EGFR
MET
VHL

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Papillary renal cell carcinoma: current progress and future directions.PMID 24629521Read ↗

Papillary renal cell carcinoma: A review of the current therapeutic landscape.Semantic proximity Read ↗

Advanced papillary renal cell carcinoma: Epidemiology, genomic drivers, current therapies, and ongoing trials.Semantic proximity Read ↗

Renal cell carcinoma: new insights and challenges for a clinician scientist.Semantic proximity Read ↗

Recent progress in non-clear cell renal cell carcinoma: biology and therapeutic strategiesSemantic proximity Read ↗

Kidney cancer: identification of novel targets for therapy.Semantic proximity Read ↗

Current updates and future perspectives on the management of renal cell carcinoma.Semantic proximity Read ↗

Insights into the Genetic Basis of the Renal Cell Carcinomas from The Cancer Genome AtlasSemantic proximity Read ↗

Genetic Alterations in Renal Cancers: Identification of The Mechanisms Underlying Cancer Initiation and Progression and of Therapeutic TargetsSemantic proximity Read ↗

Papillary renal cell carcinoma, formerly known as Type 2: a single institutional study addressing histologic and molecular features.Semantic proximity Read ↗

Navigating the Current Landscape of Non-Clear Cell Renal Cell Carcinoma: A Review of the LiteratureSemantic proximity Read ↗

Renal cell carcinoma.Semantic proximity Read ↗

Renal cell carcinoma: a review of biology and pathophysiologySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.